» Articles » PMID: 28138518

Decellularized Zebrafish Cardiac Extracellular Matrix Induces Mammalian Heart Regeneration

Overview
Journal Sci Adv
Specialties Biology
Science
Date 2017 Feb 1
PMID 28138518
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Heart attack is a global health problem that leads to significant morbidity, mortality, and health care burden. Adult human hearts have very limited regenerative capability after injury. However, evolutionarily primitive species generally have higher regenerative capacity than mammals. The extracellular matrix (ECM) may contribute to this difference. Mammalian cardiac ECM may not be optimally inductive for cardiac regeneration because of the fibrotic, instead of regenerative, responses in injured adult mammalian hearts. Given the high regenerative capacity of adult zebrafish hearts, we hypothesize that decellularized zebrafish cardiac ECM (zECM) made from normal or healing hearts can induce mammalian heart regeneration. Using zebrafish and mice as representative species of lower vertebrates and mammals, we show that a single administration of zECM, particularly the healing variety, enables cardiac functional recovery and regeneration of adult mouse heart tissues after acute myocardial infarction. zECM-treated groups exhibit proliferation of the remaining cardiomyocytes and multiple cardiac precursor cell populations and reactivation of ErbB2 expression in cardiomyocytes. Furthermore, zECM exhibits pro-proliferative and chemotactic effects on human cardiac precursor cell populations in vitro. These contribute to the structural preservation and correlate with significantly higher cardiac contractile function, notably less left ventricular dilatation, and substantially more elastic myocardium in zECM-treated hearts than control animals treated with saline or decellularized adult mouse cardiac ECM. Inhibition of ErbB2 activity abrogates beneficial effects of zECM administration, indicating the possible involvement of ErbB2 signaling in zECM-mediated regeneration. This study departs from conventional focuses on mammalian ECM and introduces a new approach for cardiac tissue regeneration.

Citing Articles

Autophagy in Tissue Repair and Regeneration.

Moreno-Blas D, Adell T, Gonzalez-Estevez C Cells. 2025; 14(4).

PMID: 39996754 PMC: 11853389. DOI: 10.3390/cells14040282.


Interleukin-10 exhibit dose-dependent effects on macrophage phenotypes and cardiac remodeling after myocardial infarction.

Zhang J, Rizk R, Li X, Lee B, Matthies M, Bietz K Front Physiol. 2025; 15:1481460.

PMID: 39882328 PMC: 11774956. DOI: 10.3389/fphys.2024.1481460.


Neutrophil-derived apoptotic body membranes-fused exosomes targeting treatment for myocardial infarction.

Wang J, Li J, Su G, Zhang Y, Wang Z, Jia Y Regen Biomater. 2025; 12:rbae145.

PMID: 39866384 PMC: 11757162. DOI: 10.1093/rb/rbae145.


The role of the extracellular matrix in cardiac regeneration.

Wang X, Yu S, Xie L, Xiang M, Ma H Heliyon. 2025; 11(1):e41157.

PMID: 39834404 PMC: 11745795. DOI: 10.1016/j.heliyon.2024.e41157.


Decellularization of fish tissues for tissue engineering and regenerative medicine applications.

Chen W, Chen M, Chen S, Wang S, Huang Z, Zhang L Regen Biomater. 2025; 12:rbae138.

PMID: 39776859 PMC: 11703550. DOI: 10.1093/rb/rbae138.


References
1.
Williams C, Sullivan K, Black 3rd L . Partially Digested Adult Cardiac Extracellular Matrix Promotes Cardiomyocyte Proliferation In Vitro. Adv Healthc Mater. 2015; 4(10):1545-54. PMC: 4504755. DOI: 10.1002/adhm.201500035. View

2.
Bonfanti L . From hydra regeneration to human brain structural plasticity: a long trip through narrowing roads. ScientificWorldJournal. 2011; 11:1270-99. PMC: 5720118. DOI: 10.1100/tsw.2011.113. View

3.
Mollova M, Bersell K, Walsh S, Savla J, Das L, Park S . Cardiomyocyte proliferation contributes to heart growth in young humans. Proc Natl Acad Sci U S A. 2013; 110(4):1446-51. PMC: 3557060. DOI: 10.1073/pnas.1214608110. View

4.
Ranganath S, Levy O, Inamdar M, Karp J . Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell. 2012; 10(3):244-58. PMC: 3294273. DOI: 10.1016/j.stem.2012.02.005. View

5.
Wassenaar J, Gaetani R, Garcia J, Braden R, Luo C, Huang D . Evidence for Mechanisms Underlying the Functional Benefits of a Myocardial Matrix Hydrogel for Post-MI Treatment. J Am Coll Cardiol. 2016; 67(9):1074-1086. PMC: 4779189. DOI: 10.1016/j.jacc.2015.12.035. View